The Double-Edged Shot: Pfizer's mRNA Flu Vaccine Looks Great, But Here's the Hiccup

The Siren Song of Scale: Why Big Pharma's Mega-Mergers So Often Fall Flat

The Great Weight Race: Can New Contenders Navigate the Treacherous Path of Next-Gen Obesity Drugs?

The Bidding Blitz: Why Novo Nordisk's Loss to Pfizer Isn't Just About Money

The Billion-Dollar Battle for a Breakthrough: Pfizer's Big Bet on Oral Obesity Drugs

The Race for a Breakthrough: Pfizer's Bold Bet on Battling Obesity, Outmaneuvering Novo Nordisk

The Great Pharmaceutical Scramble: Pfizer Bags Metsea in High-Stakes Obesity Drug Duel

The Billion-Dollar Battle for the Future of Weight Loss: Pfizer Jumps into the Ring

The Weight of Ambition: Pfizer’s Bold Move into the Obesity Race

The Battle for the Next Blockbuster: Pfizer Steps Up in the Obesity Drug Wars

The Pharmaceutical Thunderdome: Pfizer's Bold Play in the Billion-Dollar Battle for Obesity Drugs

The Great GLP-1 Gold Rush: Pfizer Jumps into the Billion-Dollar Battle for Weight Loss Dominance

The Great Weigh-In: Pfizer's Bold Bet in the Billion-Dollar Battle for Obesity Drug Dominance

The Great Weight-Loss Race: Pfizer's Billion-Dollar Gambit to Conquer Obesity

The High-Stakes Game of Weight Loss: Pfizer's Gambit in the GLP-1 Gold Rush

The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp

The Billion-Dollar Beatdown: How Novo Nordisk Clinched Metsera in a High-Stakes Pharma Showdown

The Earnings Game: Big Tech's Bumpy Ride and the Surprises That Moved Markets

The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal

The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

Alberta's Vaccination Drive Accelerates: Second Phase of COVID-19 Bookings Now Open

A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk

Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope

The Pharmaceutical Tsunami: How a Second Trump Term Could Reshape Drug Pricing, Medicare, and Vaccines

Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape

President Trump Unveils Landmark Deals: Slashing Drug Costs and Boosting COVID-19 Testing

America's Crossroads: Military Overhauls, Economic Shifts, and Unfolding Dramas

A Pharmaceutical Powerhouse Pivots: Pfizer Embraces Trump's 'Most Favored Nation' Pricing

TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

A Landmark Deal: Pfizer Slashes Drug Costs for Medicaid Patients in Trump Administration Agreement

Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts

TrumpRx Unleashes Massive 85% Discounts on Pfizer Drugs: A Game Changer?

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

Trump Hails Landmark Pfizer Deal: $70 Million US Investment and Drug Price Cuts Announced